Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 144

Cited In for PubMed (Select 16192481)

1.

Pleiotropic Effects of Levofloxacin, Fluoroquinolone Antibiotics, against Influenza Virus-Induced Lung Injury.

Enoki Y, Ishima Y, Tanaka R, Sato K, Kimachi K, Shirai T, Watanabe H, Chuang VT, Fujiwara Y, Takeya M, Otagiri M, Maruyama T.

PLoS One. 2015 Jun 18;10(6):e0130248. doi: 10.1371/journal.pone.0130248. eCollection 2015.

2.

Impulsive Enzymes: A New Force in Mechanobiology.

Butler PJ, Dey KK, Sen A.

Cell Mol Bioeng. 2015 Mar 1;8(1):106-118.

PMID:
26019728
3.

Comparison of serum hemagglutinin and neuraminidase inhibition antibodies after 2010-2011 trivalent inactivated influenza vaccination in healthcare personnel.

Laguio-Vila MR, Thompson MG, Reynolds S, Spencer SM, Gaglani M, Naleway A, Ball S, Bozeman S, Baker S, Martínez-Sobrido L, Levine M, Katz J, Fry AM, Treanor JJ.

Open Forum Infect Dis. 2015 Jan 3;2(1):ofu115. doi: 10.1093/ofid/ofu115. eCollection 2015 Jan.

4.

The Tamiflu fiasco and lessons learnt.

Gupta YK, Meenu M, Mohan P.

Indian J Pharmacol. 2015 Jan-Feb;47(1):11-6. doi: 10.4103/0253-7613.150308.

5.

Structural characterization of a protective epitope spanning A(H1N1)pdm09 influenza virus neuraminidase monomers.

Wan H, Yang H, Shore DA, Garten RJ, Couzens L, Gao J, Jiang L, Carney PJ, Villanueva J, Stevens J, Eichelberger MC.

Nat Commun. 2015 Feb 10;6:6114. doi: 10.1038/ncomms7114.

6.

CISAPS: Complex Informational Spectrum for the Analysis of Protein Sequences.

Chrysostomou C, Seker H, Aydin N.

Adv Bioinformatics. 2015;2015:909765. doi: 10.1155/2015/909765. Epub 2015 Jan 6.

7.

Detection of a transient R292K mutation in influenza A/H3N2 viruses shed for several weeks by an immunocompromised patient.

Babady NE, Laplante JM, Tang YW, St George K.

J Clin Microbiol. 2015 Apr;53(4):1415-8. doi: 10.1128/JCM.02845-14. Epub 2015 Jan 14.

PMID:
25588658
8.

Discovery of potential drugs for human-infecting H7N9 virus containing R294K mutation.

He JY, Li C, Wu G.

Drug Des Devel Ther. 2014 Dec 1;8:2377-90. doi: 10.2147/DDDT.S74061. eCollection 2014.

9.

Flipping in the pore: discovery of dual inhibitors that bind in different orientations to the wild-type versus the amantadine-resistant S31N mutant of the influenza A virus M2 proton channel.

Wu Y, Canturk B, Jo H, Ma C, Gianti E, Klein ML, Pinto LH, Lamb RA, Fiorin G, Wang J, DeGrado WF.

J Am Chem Soc. 2014 Dec 31;136(52):17987-95. doi: 10.1021/ja508461m. Epub 2014 Dec 18.

10.

A dual character of flavonoids in influenza A virus replication and spread through modulating cell-autonomous immunity by MAPK signaling pathways.

Dong W, Wei X, Zhang F, Hao J, Huang F, Zhang C, Liang W.

Sci Rep. 2014 Nov 28;4:7237. doi: 10.1038/srep07237.

11.

Therapeutic impact of human serum albumin-thioredoxin fusion protein on influenza virus-induced lung injury mice.

Tanaka R, Ishima Y, Enoki Y, Kimachi K, Shirai T, Watanabe H, Chuang VT, Maruyama T, Otagiri M.

Front Immunol. 2014 Nov 5;5:561. doi: 10.3389/fimmu.2014.00561. eCollection 2014.

12.

Entry properties and entry inhibitors of a human H7N9 influenza virus.

Si Y, Li J, Niu Y, Liu X, Ren L, Guo L, Cheng M, Zhou H, Wang J, Jin Q, Yang W.

PLoS One. 2014 Sep 15;9(9):e107235. doi: 10.1371/journal.pone.0107235. eCollection 2014.

13.

Evaluation of the Alere I influenza A&B nucleic acid amplification test by use of respiratory specimens collected in viral transport medium.

Bell JJ, Selvarangan R.

J Clin Microbiol. 2014 Nov;52(11):3992-5. doi: 10.1128/JCM.01639-14. Epub 2014 Sep 10.

14.

Neuraminidase Inhibitors from the Fermentation Broth of Phellinus linteus.

Hwang BS, Lee MS, Lee SW, Lee IK, Seo GS, Choi HJ, Yun BS.

Mycobiology. 2014 Jun;42(2):189-92. doi: 10.5941/MYCO.2014.42.2.189. Epub 2014 Jun 30.

15.

Verdinexor, a novel selective inhibitor of nuclear export, reduces influenza a virus replication in vitro and in vivo.

Perwitasari O, Johnson S, Yan X, Howerth E, Shacham S, Landesman Y, Baloglu E, McCauley D, Tamir S, Tompkins SM, Tripp RA.

J Virol. 2014 Sep 1;88(17):10228-43. doi: 10.1128/JVI.01774-14. Epub 2014 Jun 25.

16.

Zanamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments.

Heneghan CJ, Onakpoya I, Thompson M, Spencer EA, Jones M, Jefferson T.

BMJ. 2014 Apr 9;348:g2547. doi: 10.1136/bmj.g2547. Review.

17.
18.

Prospective surveillance and molecular characterization of seasonal influenza in a university cohort in Singapore.

Virk RK, Tambyah PA, Inoue M, Lim EA, Chan KW, Chua C, Tan BH.

PLoS One. 2014 Feb 10;9(2):e88345. doi: 10.1371/journal.pone.0088345. eCollection 2014.

19.

How sticky should a virus be? The impact of virus binding and release on transmission fitness using influenza as an example.

Handel A, Akin V, Pilyugin SS, Zarnitsyna V, Antia R.

J R Soc Interface. 2014 Jan 15;11(92):20131083. doi: 10.1098/rsif.2013.1083. Print 2014 Mar 6.

20.

Importance of ligand conformational energies in carbohydrate docking: Sorting the wheat from the chaff.

Nivedha AK, Makeneni S, Foley BL, Tessier MB, Woods RJ.

J Comput Chem. 2014 Mar 15;35(7):526-39. doi: 10.1002/jcc.23517. Epub 2013 Dec 29.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk